| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Aziyo Biologics (NASDAQ:AZYO) reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
Aziyo Biologics beat estimated earnings by 9.26%, reporting an EPS of $-0.49 versus an estimate of $-0.54.
Revenue was up $1.55 million from the same period last year.
Last quarter the company beat on EPS by $0.31 which was followed by a 17.65% increase in the share price the next day.
Here's a look at Aziyo Biologics's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.69 | -0.66 | -0.56 | -0.62 |
| EPS Actual | -0.38 | -0.73 | -0.69 | -0.60 |
| Revenue Estimate | 12.55M | 12.37M | 11.58M | 10.78M |
| Revenue Actual | 12.66M | 12.39M | 12.64M | 11.49M |
To track all earnings releases for Aziyo Biologics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: AZYO
